Mural Oncology Plc (MURA)

$4.00 +0.31 (8.40%)
Market Cap 62.80M
Revenue (ttm) 0.00
Net Income (ttm) -207.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 342,900
Avg Vol 209,528
Day's Range N/A - N/A
Shares Out 17.02M
Stochastic %K 57%
Beta 3.83
Analysts Strong Sell
Price Target $16.00

Latest News on MURA

Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts

Jan 9, 2025, 4:00 PM EST - 8 days ago

Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 3, 2024, 4:15 PM EST - 6 weeks ago

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer

Nov 20, 2024, 4:15 PM EST - 2 months ago

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer

Mural Oncology to Participate in Two Upcoming Investor Conferences

Nov 11, 2024, 7:00 AM EST - 2 months ago

Mural Oncology to Participate in Two Upcoming Investor Conferences

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Nov 7, 2024, 4:15 PM EST - 2 months ago

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Oct 7, 2024, 7:00 AM EDT - 3 months ago

Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi

Sep 23, 2024, 7:00 AM EDT - 4 months ago

Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi

Mural Oncology to Host First Virtual Investor Day on September 26, 2024

Sep 10, 2024, 7:00 AM EDT - 4 months ago

Mural Oncology to Host First Virtual Investor Day on September 26, 2024

Mural Oncology to Present at Two Upcoming Investor Conferences

Aug 27, 2024, 7:00 AM EDT - 5 months ago

Mural Oncology to Present at Two Upcoming Investor Conferences

Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress

Aug 13, 2024, 7:15 AM EDT - 5 months ago

Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress

Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors

Jul 31, 2024, 7:00 AM EDT - 6 months ago

Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors

Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference

Jun 5, 2024, 4:15 PM EDT - 8 months ago

Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference

Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update

May 14, 2024, 7:00 AM EDT - 8 months ago

Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update

Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Apr 24, 2024, 4:00 PM EDT - 9 months ago

Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting

Apr 9, 2024, 4:00 PM EDT - 10 months ago

Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting

Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Mar 26, 2024, 7:00 AM EDT - 10 months ago

Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting

Mar 5, 2024, 4:35 PM EST - 11 months ago

Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting

Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value

Mar 3, 2024, 11:53 PM EST - 11 months ago

Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value

Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference

Feb 27, 2024, 7:00 AM EST - 11 months ago

Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference